The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair

References

• Jacobson S, Goldberg J, Miles TP, et al. Hip fracture incidence among the old and very old: a population based study of 745 435 cases. Am J Public Health 1990;80:871–3
   PubMed Web of Science ®Google Scholar
• Adachi JD, Ioannidis G, Berger C, et al. The influence of osteoporotic fractures on health related quality of life in community dwelling men and women across Canada. Osteoporos Int 2001;12:903–8
   PubMed Web of Science ®Google Scholar
• Hannan E, Magaziner J, Wang J, et al. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. J Am Med Assoc 2001;285:2736–42
   PubMed Web of Science ®Google Scholar
• Kane RL, Chen Q, Finch M, Blewett L, Burns R, Moskowitz M. Functional outcomes of posthospital care for stroke and hip fracture patients under medicare. J Am Geriatr Soc 1998;46:1525–33
   PubMed Web of Science ®Google Scholar
• Randell A, Nguyen T, Bhalerao N, et al. Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int 2000;11:460–6
   PubMed Web of Science ®Google Scholar
• Brainsky A, Glick H, Lydick E, et al. The economic cost of hip fractures in community dwelling older adults: a prospective study. J Am Geriatr Soc 1997;45:281–7
   PubMed Web of Science ®Google Scholar
• Zimmerman SI, Chandler J, Hawkes W, et al. Effect of fracture on the health care use of nursing home residents. Arch Int Med 2002;162:1502–8
   PubMed Web of Science ®Google Scholar
• Colon-Emeric C, Kuchibhatla M, Pieper C, et al. The contribution of hip fracture to subsequent fracture: data from two longitudinal studies. Osteoporos Int 2003;14(11):879–83
   Google Scholar
• Fox KM, Magaziner J, Hawkes WG, et al. Loss of bone density and lean body mass after hip fracture. Osteoporos Int 2000;11:31–5
   PubMed Web of Science ®Google Scholar
• Dirschl D, Piedrahita L, Henderson R. Bone mineral density 6years after a hip fracture: a prospective longitudinal study. Bone 2000;26: 95–8
   Google Scholar
• Karlsson M, Nilsson J, Sernbo I, Redlund-Johnell I, Johnell O, Obrant K. Changes of bone mineral mass and soft tissue composition after hip fracture. Bone 1996;18:19–22
   Google Scholar
• Colon-Emeric C, Yballe L, Sloane R, et al. Expert physician recommendations and current practice patterns for evaluating and treating men with osteoporotic hip fracutre. J Am Geriatr Soc 2000;48:1261–3
   Google Scholar
• Kamel H, Hussain M, Tariq S, et al. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 2000;109:326–8
   PubMed Web of Science ®Google Scholar
• Torgerson D, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998;57:378–9
   PubMed Web of Science ®Google Scholar
• Harris S, Watts N, Geneant H, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. J Am Med Assoc 1999;282:1344–52
   PubMed Web of Science ®Google Scholar
• Black D, Cummings S, Karpf D, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535–41
   PubMed Web of Science ®Google Scholar
• Chestnut C, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 2000;109:267–76
   PubMed Web of Science ®Google Scholar
• Ettinger B, Black D, Mitlak B, et al. Reduction of vertebral fracture risk in postmenopausal women treated with raloxifene: results from a 3-year randomized clinical trial. J Am Med Assoc 1999;282:637–45
   PubMed Web of Science ®Google Scholar
• Neer R, Arnaud C, Zanchetta J, et al. Effect of parathyroid hormone on fractures and bone mineral density in postmenopausal women with osteoporosis. New Engl J Med 2001;344:1434–41
   PubMed Web of Science ®Google Scholar
• Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. New Engl J Med 2000;343:604–10
   PubMed Web of Science ®Google Scholar
• McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. New Engl J Med 2001;344(5):333–40
   PubMed Web of Science ®Google Scholar
• Levis S, Quandt SA, Thompson D et al. Alendronate reduces the risk of multiple symptomatic fractures: results for the Fracture Intervention Trial. J Am Geriatr Soc 2002;50(3):409–15
   PubMed Web of Science ®Google Scholar
• Reid I, Brown J, Burckhardt P, et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. New Engl J Med 2002;346:653–61
   PubMed Web of Science ®Google Scholar
• Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Int Med 1990;113(12):941–8
   PubMed Web of Science ®Google Scholar
• NIH Consensus Statement: osteoporosis prevention, diagnosis and therapy, vol. 17. National Institutes of Health; 2000
   Google Scholar
• Brown JP, Josse RG, et al. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 2002;167(Suppl 10):S1–34
   Web of Science ®Google Scholar
• Chapuy M, Arlot M, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. New Engl J Med 1992;327:1637–42
   PubMed Web of Science ®Google Scholar
• Rosen C, Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. New Engl J Med 2003;348:1503–4
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622–9
   Google Scholar
• Genant H, Chun W, Van Kuijk C, Nevitt M. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137–48
   PubMed Web of Science ®Google Scholar
• Szulc P, Munoz F, Marchand F, Delmas P. Semiquantitative evaluation of prevalent vertebral deformities in men and their relationship with osteoporosis: the MINOS study. Osteoporos Int 2001;12:302–10
   PubMed Web of Science ®Google Scholar